Skip to main content

Light-Based Control of Bacteria Aims to Quell Antibiotic Resistance






Bacterial resistance to antibiotics is a growing challenge for the healthcare and environmental sectors. Bacterial persistence is usually the first step leading to resistance, which involves a change in an organism’s genome.

In the future, it may be possible to address antibiotic persistence and resistance by using light to regulate bacterial response to antibiotics. A technique developed at the Polytechnic University of Milan (Politecnico di Milano), by a team participating in the Engineering of Bacteria to See Light (EOS) project, allows bacteria to sense light and convert light energy into electrical signals across the bacterial membrane, without the need for genetic modification.

To demonstrate photocontrol of bacterial membrane potential, the researchers attached phototransducing molecules to bacterial surfaces to make the bacteria light-responsive. When the researchers exposed the phototransducers to light, the electrical potential of the bacterial membrane changed.

The researchers used Ziapin2, a photoswitchable chemical compound, with two broad-spectrum antibiotics, Kanamycin and Ampicillin. These antibiotics have different modes of activation. Kanamycin requires cytosolic uptake to inhibit protein synthesis, while Ampicillin targets cell wall polymerization at the cell envelope.

When the researchers exposed B. subtilis to Kanamycin and Ziapin2 through photoactivation with 470-nm light, the previously lethal effects of Kanamycin were markedly reduced. In contrast, Ampicillin-treated samples remained largely unaffected by light-induced membrane modulation.

“This interplay between light and electrical signaling allows us to control key biological processes such as movement, biofilm formation, and antibiotic sensitivity,” professor Giuseppe Maria Paternò said. “By manipulating the membrane potential on demand, we can influence antibiotic uptake and restore or even enhance the effectiveness of treatments against resistant strains.”

Possible applications for the technique include developing next-generation antimicrobial platforms that use light to target resistant pathogens, and biocompatible, light-guided “bacterial robots” capable of delivering drugs to specific areas of the body — even the areas that are hard to reach, such as the gastrointestinal tract.

More broadly, the potential to modulate and control the interaction between bacterial cells and antibiotics using light and synthetic photoswitches, without genetic engineering, in real time, represents a first step in developing a new approach to combating antibiotic resistance.

In the future, photoswitchable chemical compounds could be membrane-targeted and tailored to work with different classes of antibiotics, advancing bacterial bioelectric regulation and its applications in antimicrobial therapies.


Bio Photonics Research Award

Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee

#MeatAnalysis #FluorescenceTech #FoodQuality #FoodSafety #SpectroscopyInFood #MeatAuthentication #RapidDetection #FoodScience #MeatFreshness #MolecularDetection #FoodIndustryInnovation #NonDestructiveTesting #FoodMonitoring #SpectroscopyApplications #QualityControl #AdvancedSpectroscopy #MeatSpoilageDetection #FoodIntegrity #SmartFoodTesting #RealTimeAnalysis #FoodAuthenticity #FoodSafetyInnovation #SpectroscopyResearch #NextGenFoodSafety #InnovativeFoodScience,

Comments

Popular posts from this blog

Abrisa Technologies Acquires Agama Glass Technologies

SANTA PAULA, Calif. — Abrisa Technologies, a provider of custom glass optics and thin film coatings and a subsidiary of HEF Photonics, has acquired Agama Glass Technologies, a manufacturer of etched anti-glare glass and technical glass processing. The acquisition, Abrisa said, expands its manufacturing footprint and adds a vertically integrated solution for chemically etched anti-glare display glass. According to Abrisa, Clarksburg, West Virginia-based Agama operates North America’s only high-volume technical glass etching facility. Agama's flagship product, AgamaEtch, is used in high-performance display and optics applications. The company's 85,000 sq ft facility also offers precision glass fabrication, chemical strengthening, and silk-screen printing, serving markets such as avionics, defense, medical, industrial, and touchscreen displays. Combined with Abrisa Technologies’ and HEF Photonics’ thin-film coating and surface engineering capabilities, Agama's offerings wi...

How Biophotonics Is Harnessing Light for Health And Science

Fifty or so years ago French physicist Pierre Aigrain coined the term photonics as a research field whose goal was to use light to perform functions that traditionally fell within the typical domain of electronics, such as telecommunications, and information processing. Or maybe it was John Campbell who, in a letter sent to Gotthard Gunther in 1954, wrote, “Incidentally, I’ve decided to invent a new science — photonics. It bears the same relationship to Optics that electronics does to electrical engineering. Photonics, like electronics, will deal with the individual units; optics and EE deal with the group phenomena! And note that you can do things with electronics that are impossible in electrical engineering!” Naming rights aside, the field of photonics began in earnest between 1958 and 1960 with the invention of the maser and the laser. The laser diode followed during the 1970s, optical fibers and the erbium-doped fiber amplifier after that, and, pretty soon, the telecommunications...

Laser Method Enables Fast & Precise Blood Vessels in Hydrogel

Researchers from Vienna University of Technology (TU Wien) and Keio University have found a way to create artificial blood vessels in miniature organ models in a quick and reproducible manner. The method utilizes ultrashort laser pulses in the femtosecond range to write highly 3D structures into a hydrogel. In biomedical research, organs-on-a-chip are becoming increasingly important: By cultivating tissue structures in precisely controlled microfluidic chips, it is possible to conduct research much more accurately than in experiments involving living humans or animals. However, there has been a major obstacle: such mini-organs are incomplete without blood vessels. To facilitate systematic studies and ensure meaningful comparisons with living organisms, a network of perfusable blood vessels and capillaries must be created — in a way that is precisely controllable and reproducible. “We can create channels spaced only a hundred micrometers apart. That’s essential when you would like to...